Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 4
2018 5
2019 6
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Related Articles by Review for PMID: 31305971

19 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. PMID: 31305971 Free Books & Documents. Review.
Pharmacoeconomic Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adults patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment) [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun. PMID: 31305974 Free Books & Documents. Review.
The Discovery and Development of Liraglutide and Semaglutide.
Knudsen LB, Lau J. Knudsen LB, et al. Front Endocrinol (Lausanne). 2019 Apr 12;10:155. doi: 10.3389/fendo.2019.00155. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31031702 Free PMC article. Review.
Clinical Review Report: Ixekizumab (Taltz): (Eli Lilly Canada Inc.): Indication: Treatment of adult patients with active psoriatic arthritis who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD). Taltz can be used alone or in combination with a conventional DMARD (e.g., methotrexate) [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug. PMID: 30973685 Free Books & Documents. Review.
Clinical Review Report: adalimumab (Humira) [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr. PMID: 30912894 Free Books & Documents. Review.
Clinical Review Report: Dapagliflozin (Forxiga) [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr. PMID: 30883069 Free Books & Documents. Review.
Clinical Review Report: Lixisenatide (Adlyxine): (Sanofi-aventis Canada Inc.): Indication: As an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with metformin, a sulfonylurea (alone or with metformin), pioglitazone (alone or with metformin), a basal insulin (alone or with metformin), when the therapy listed above does not provide adequate glycemic control [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Dec. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Dec. PMID: 30543384 Free Books & Documents. Review.
19 results
-